Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

(603392)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-12-05
137.45 CNY   -8.20%
11/07China's super-rich see fortunes plunge as economy slows
RE
10/17Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
10/12Wantai Biological Pharmacy Sees Up to 232% Profit Growth in January-September Period
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
11/30/2022 12/01/2022 12/02/2022 12/05/2022 12/06/2022 Date
162.81 151.99 152.63 149.72 137.45 Last
5110026 5829202 2230035 5961271 11070610 Volume
+2.40% -6.65% +0.42% -1.91% -8.20% Change
Estimated financial data (e)
Sales 2022 11 489 M 1 643 M 1 643 M
Net income 2022 4 431 M 634 M 634 M
Net Debt 2022 - - -
P/E ratio 2022 25,9x
Yield 2022 0,17%
Sales 2023 14 023 M 2 005 M 2 005 M
Net income 2023 5 725 M 819 M 819 M
Net Debt 2023 - - -
P/E ratio 2023 21,0x
Yield 2023 0,19%
Capitalization 125 B 17 809 M 17 809 M
Capi. / Sales 2022 10,8x
Capi. / Sales 2023 8,88x
Nbr of Employees 3 103
Free-Float 16,5%
More Financials
Company
Beijing Wantai Biopharmaceutical Co., Ltd. is a company mainly engaged in the research and development, production and sales of in-vitro diagnostics. The Company produces and sells in-vitro diagnostics, in-vitro diagnostic equipment and vaccines. The Company is also engaged in the sales of agent products. The in-vitro diagnostics include: enzyme-linked immunosorbent assay (ELISA) reagents, chemiluminescence... 
Sector
Pharmaceuticals
Calendar
03/24Earnings Release
More about the company
Ratings of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
11/07China's super-rich see fortunes plunge as economy slows
RE
10/17Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
10/12Wantai Biological Pharmacy Sees Up to 232% Profit Growth in January-September Period
MT
08/26Wantai Biological Pharmacy's H1 Profit Nearly Quadruples, Meeting Target
MT
08/25Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
08/06Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announces an Equity Buyback for..
CI
08/05Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. authorizes a Buyback Plan.
CI
07/23Xiamen Innovax Biotech CO., LTD. announced that it has received CNY 400 million in fund..
CI
07/14Wantai Biological Pharmacy's H1 Profit Nearly Quadrupled, Early Estimates Show
MT
06/07Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. announced that it has received ..
CI
05/13Wantai Biological Wins Approval to Sell HPV Vaccine in Morocco
MT
04/15Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
02/14Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Reports Earnings Results for th..
CI
02/11Chinese Shares End Lower; Pharmaceutical Stlocks Suffer Huge Losses After WuXi Biologic..
MT
2021Bottled water, vaccines and electric vehicles propel China's biggest earners
RE
More news
News in other languages on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
10/17Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. annonce ses résultats pour les ..
10/12La pharmacie biologique de Wantai enregistre une croissance de ses bénéfices de 232 % e..
08/26Le bénéfice de Wantai Biological Pharmacy au premier semestre a presque quadruplé, atte..
08/25Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. annonce ses résultats pour le s..
08/06Beijing Wantai Biological Pharmacy Enterprise Co., ..
More news
ETFs positioned on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
KraneShares MSCI All China Health Care Inde...1.49%6.67%China
VanEck Vectors ChinaAMC A-Share ETF - USD1.08%7.78%-China
VanEck China New Economy ETF - Distributing - AUD1.07%4.42%-NC
VanEck New China ESG - USD0.97%4.87%-NC
Global X MSCI China Health Care ETF - USD0.63%4.86%China
More ETFs positioned on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Chart BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Duration : Period :
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 137,45
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Zi Xin Qiu General Manager & Director
Yi Yong Zhao Chief Financial Officer
Qing Chao Xing Chairman-Supervisory Board
Shan Shan Zhong Chairman
Yi Min Li Director & Chief Engineer